CMA
61
-3
PGR
59
-3
MTCH
20
-8
BEN
50
9
SYY
49
9
ICE
59
-3
KLAC
38
-6
MS
77
-2
UPS
48
2
YUM
43
-6
ZTS
47
2
OMC
50
-16
EQR
54
3
WEC
53
5
BSX
64
-3
GRMN
67
-4
MSI
72
-3
WHR
65
-5
CB
57
2
AON
54
2
CMA
61
-3
PGR
59
-3
MTCH
20
-8
BEN
50
9
SYY
49
9
ICE
59
-3
KLAC
38
-6
MS
77
-2
UPS
48
2
YUM
43
-6
ZTS
47
2
OMC
50
-16
EQR
54
3
WEC
53
5
BSX
64
-3
GRMN
67
-4
MSI
72
-3
WHR
65
-5
CB
57
2
AON
54
2
Financhill
Back

iShares MSCI Australia ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

EWA
iShares MSCI Australia ETF

Last Price:
25.58
Seasonality Move:
0.39%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
iShares MSCI Australia ETF (EWA) is a Sell

Is iShares MSCI Australia ETF a Buy, Sell or Hold?

  • The current iShares MSCI Australia ETF [EWA] share price is $25.57. The Score for EWA is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EWA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EWA Stock Price Chart

What is iShares MSCI Australia ETF's stock price today?

  • The iShares MSCI Australia ETF share price today is $25.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWA is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EWA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 43.94 Sell
Chaikin Money Flow: -290919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.54 - 26.3) Sell
Bollinger Bands (100): (24.69 - 26.39) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EWA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.77 Sell
20-day SMA: 25.78 Sell
50-day SMA: 26.17 Sell
200-day SMA: 24.87 Buy
8-day EMA: 25.67 Sell
20-day EMA: 25.82 Sell
50-day EMA: 25.87 Sell
200-day EMA: 24.95 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Australia ETF Earnings Growth & EWA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares MSCI Australia ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):